Announcements Trials
Browse Landscape

Status

Unknown 11Completed 8Recruiting 4Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 848Carcinoma, Non-Small-Cell Lung 549Neoplasms 510Prostatic Neoplasms 501Lung Neoplasms 312Colorectal Neoplasms 307Multiple Myeloma 292Neoplasm Metastasis 250Melanoma 241Ovarian Neoplasms 215Leukemia, Myeloid, Acute 208Pancreatic Neoplasms 207Squamous Cell Carcinoma of Head and Neck 173Carcinoma, Renal Cell 165Recurrence 162Stomach Neoplasms 161Carcinoma, Hepatocellular 160Lymphoma 156Brain Neoplasms 152Glioblastoma 147Uterine Cervical Neoplasms 144Lymphoma, Non-Hodgkin 141Head and Neck Neoplasms 140Triple Negative Breast Neoplasms 136Leukemia, Lymphocytic, Chronic, B-Cell 136Urinary Bladder Neoplasms 135Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Colonic Neoplasms 115Hematologic Neoplasms 113Lymphoma, Follicular 112

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Prolactinoma × Clear all
NCT03665064 2026-03-16

Long Term Outcome Study in Patients With Pituitary Disorders

University of Alberta

Active not recruiting
1,500 enrolled
Endocrine

Acromegaly, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma

NCT06936813 2026-01-08

The PROMISE Survey

University Hospital, Basel, Switzerland

Active not recruiting
530 enrolled
Endocrine

Pituitary Neoplasms, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡